BioCentury | Dec 15, 2016
Targets & Mechanisms

Keeping the Gas off AXL

...Solid tumors Preclinical Genmab A/S (CSE:GEN) HuMax-AXL-ADC ADC targeting AXL Lung cancer; solid tumors Preclinical Oribase Pharma...
...is unclear whether or to what extent they inhibit AXL signaling. The third, ORB0003 from Oribase Pharma...
...South San Francisco, Calif. Genmab A/S (CSE:GEN), Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Oribase Pharma...
BioCentury | Mar 13, 2014
Cover Story

Killer targets in metastasis

...Other companies with AXL inhibitors in preclinical development for cancer include Tolero Pharmaceuticals Inc. and Oribase Pharma...
...Martinsried, Germany Medical University Innsbruck , Innsbruck, Austria Meryx Inc. , Chapel Hill, N.C. Oribase Pharma...
BioCentury | Mar 13, 2014
Distillery Therapeutics

Indication: Cancer

...in Phase I or earlier testing to treat various cancers. Tolero Pharmaceuticals Inc. and partner Oribase Pharma...
Items per page:
1 - 3 of 3
BioCentury | Dec 15, 2016
Targets & Mechanisms

Keeping the Gas off AXL

...Solid tumors Preclinical Genmab A/S (CSE:GEN) HuMax-AXL-ADC ADC targeting AXL Lung cancer; solid tumors Preclinical Oribase Pharma...
...is unclear whether or to what extent they inhibit AXL signaling. The third, ORB0003 from Oribase Pharma...
...South San Francisco, Calif. Genmab A/S (CSE:GEN), Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Oribase Pharma...
BioCentury | Mar 13, 2014
Cover Story

Killer targets in metastasis

...Other companies with AXL inhibitors in preclinical development for cancer include Tolero Pharmaceuticals Inc. and Oribase Pharma...
...Martinsried, Germany Medical University Innsbruck , Innsbruck, Austria Meryx Inc. , Chapel Hill, N.C. Oribase Pharma...
BioCentury | Mar 13, 2014
Distillery Therapeutics

Indication: Cancer

...in Phase I or earlier testing to treat various cancers. Tolero Pharmaceuticals Inc. and partner Oribase Pharma...
Items per page:
1 - 3 of 3